Contrast-Enhanced Spectral Mammography (CESM)
Clinical trial NCT06311695 · UNKNOWN
Trial details
- NCT number
- NCT06311695
- Sponsor
- European Institute of Oncology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-16
- Primary completion
- 2025-02-28
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.